Document is current
Any future updates will be listed below
-
Authors
Jones, Gieira S. https://orcid.org/0000-0001-9537-6470
Hoadley, Katherine A.
Benefield, Halei
Olsson, Linnea T.
Hamilton, Alina M.
Bhattacharya, Arjun
Kirk, Erin L.
Tipaldos, Heather J.
Fleming, Jodie M.
Williams, Kevin P.
Love, Michael I.
Nichols, Hazel B.
Olshan, Andrew F.
Troester, Melissa A.
-
Funding
Funding for this research was provided by:
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill (T32CA057726)
Cancer Research Fund of North Carolina, the Susan B Komen Foundation (OGUNC1202)
National cancer institute (P01CA151135)
National cancer institute (U54 CA156733, P50-CA58223)
- License Information
-
More Information
Article History
Received: 28 October 2021
Accepted: 16 December 2021
First Online: 16 January 2022
Declarations
:
: The University of North Carolina is an interest owner in University Genomics, the patent holder of the PAM50 assay.
